Burt Wealth Advisors reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 1.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 16,116 shares of the healthcare conglomerate’s stock after selling 252 shares during the period. UnitedHealth Group comprises 2.3% of Burt Wealth Advisors’ investment portfolio, making the stock its 13th largest holding. Burt Wealth Advisors’ holdings in UnitedHealth Group were worth $9,423,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently made changes to their positions in UNH. International Assets Investment Management LLC grew its holdings in shares of UnitedHealth Group by 78,814.4% during the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after purchasing an additional 5,290,025 shares during the last quarter. Swedbank AB bought a new stake in UnitedHealth Group in the first quarter valued at approximately $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. boosted its holdings in UnitedHealth Group by 107.8% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock valued at $1,141,113,000 after acquiring an additional 1,196,758 shares during the last quarter. Lone Pine Capital LLC bought a new stake in UnitedHealth Group in the second quarter valued at approximately $480,903,000. Finally, Dimensional Fund Advisors LP boosted its holdings in UnitedHealth Group by 30.0% in the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock valued at $1,942,956,000 after acquiring an additional 880,183 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.
UnitedHealth Group Price Performance
Shares of NYSE UNH traded up $9.19 during trading hours on Friday, reaching $614.64. 915,102 shares of the stock traded hands, compared to its average volume of 3,892,500. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The company’s 50-day simple moving average is $581.13 and its two-hundred day simple moving average is $543.74. The company has a market capitalization of $565.64 billion, a P/E ratio of 40.01, a price-to-earnings-growth ratio of 1.75 and a beta of 0.58. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $617.44.
UnitedHealth Group Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be given a dividend of $2.10 per share. The ex-dividend date is Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.37%. UnitedHealth Group’s dividend payout ratio is presently 54.72%.
Wall Street Analysts Forecast Growth
A number of research firms have issued reports on UNH. TD Cowen increased their price target on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 24th. Stephens cut their price target on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. KeyCorp started coverage on UnitedHealth Group in a report on Friday, October 11th. They set an “overweight” rating and a $675.00 price target on the stock. Finally, Wells Fargo & Company upped their target price on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $615.53.
Check Out Our Latest Analysis on UNH
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
- Five stocks we like better than UnitedHealth Group
- How to Invest in Blue Chip Stocks
- The Hottest Markets to Watch After the Fed’s 25 Bps Rate Cut
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- The Top 5 Performing S&P 500 Stocks YTD in 2024
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- L3Harris: Positioned for Gains With Trump’s Defense Policies
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.